Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
Completed
Novartis
N/A
1969-12-31
The purpose of this study is to see if it is safe and effective to give Lamisil to
HIV-positive patients with thrush (a fungal infection) that has not responded to fluconazole.
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
Completed
Novartis Pharmaceuticals
Phase 3
2004-06-01
Tinea capitis is a dermatophyte infection of the scalp hair follicles, which occurs primarily
in children. Hair loss, hair breakage, scaling, plus various degrees of erythema, pustules
and pruritus are the primary clinical signs which can be associated with tinea capitis. The
infection is caused by a relatively small group of dermatophytes in the genera Trichophyton
and Microsporum.
Terbinafine hydrochloride is a synthetic allylamine derivative antifungal agent. This study
will evaluate the efficacy and safety of terbinafine in children with tinea capitis.
Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
Completed
Novartis Pharmaceuticals
Phase 3
2006-12-01
This study is designed to assess the efficacy, safety and tolerability of a topical
formulation of terbinafine solution applied daily in patients with toenail fungus. This trial
will study patients with mild to moderate toenail fungus disease of the big toenail and their
responses to two treatment durations, 24 or 48 weeks.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
